Pfizer is about to seek US authorization for a third dose of its COVID-19 vaccine. The company says that another shot could dramatically boost immunity and maybe help ward off the latest worrisome coronavirus mutant. Research from multiple countries shows the widely used COVID-19 vaccines offer strong protection against the highly contagious Delta variant. Virus-fighting antibodies naturally wane, but public health officials would have to decide if the boosters are really needed.
To read the data from Pfizer: CLICK HERE (You will be redirected)
As we continue to be led by the science, today we are providing an update on our comprehensive #COVID19 vaccine booster strategy in light of emerging data including data relating to the #DeltaVariant. https://t.co/P0XmAGrxlt pic.twitter.com/JZ5JIIKwHC
— Pfizer Inc. (@pfizer) July 8, 2021
In an effort to stay ahead of the virus, we are preparing an updated version of the Pfizer-BioNTech #COVID19 vaccine based on the #DeltaVariant and may start clinical studies as early as August 2021. Learn more about our efforts: https://t.co/P0XmAGrxlt pic.twitter.com/5WscyTJ0Vc
— Pfizer Inc. (@pfizer) July 8, 2021
